Table 1.
Demographic or Clinical Characteristic | 0 to 59 Days From Biopsy-Confirmed Diagnosis to Treatment (n = 1,603) |
≥ 60 Days From Biopsy-Confirmed Diagnosis to Treatment (n = 183) |
P* | ||
---|---|---|---|---|---|
No. of Patients | % | No. of Patients | % | ||
Demographic | |||||
Age, years | .58 | ||||
< 45 | 254 | 16 | 27 | 15 | |
45-54 | 280 | 17 | 40 | 22 | |
55-64 | 344 | 21 | 43 | 24 | |
65-74 | 336 | 21 | 39 | 21 | |
75-84 | 314 | 20 | 26 | 14 | |
≥ 85 | 75 | 5 | 8 | 4 | |
Race | .04 | ||||
White | 906 | 57 | 89 | 49 | |
Nonwhite | 697 | 44 | 94 | 51 | |
Marital status | .99 | ||||
Married | 264 | 16 | 33 | 18 | |
Single | 225 | 14 | 26 | 14 | |
Divorced/separated | 252 | 16 | 28 | 15 | |
Widowed | 392 | 24 | 44 | 24 | |
Unknown | 470 | 29 | 52 | 28 | |
Rural/urban status† | .04 | ||||
Metropolitan | 891 | 56 | 113 | 62 | |
Nonmetropolitan | 705 | 44 | 69 | 38 | |
HPSA† | 1.00‡ | ||||
HPSA | 42 | 3 | 4 | 2 | |
Non-HPSA | 1,554 | 97 | 178 | 98 | |
Year of diagnosis | .61 | ||||
2000 | 508 | 32 | 64 | 35 | |
2001 | 548 | 34 | 62 | 34 | |
2002 | 547 | 34 | 57 | 31 | |
Tumor/cancer characteristics | |||||
Stage at diagnosis | .15 | ||||
In situ | 167 | 10 | 29 | 16 | |
Localized | 783 | 49 | 86 | 47 | |
Regional | 570 | 36 | 61 | 33 | |
Distant | 83 | 5 | 7 | 4 | |
Tumor size, mm | .70 | ||||
0-9 | 208 | 13 | 22 | 12 | |
10-19 | 411 | 26 | 52 | 28 | |
20-49 | 582 | 36 | 60 | 33 | |
≥ 50 | 166 | 10 | 17 | 9 | |
Unknown | 236 | 15 | 32 | 18 | |
Hormone receptor status | .09 | ||||
Positive | 836 | 52 | 92 | 50 | |
Negative | 298 | 19 | 25 | 14 | |
Unknown/undetermined | 469 | 29 | 66 | 36 | |
Morbidity indicators | |||||
Charlson comorbidity index | .85 | ||||
0 | 726 | 45 | 82 | 45 | |
1-2 | 587 | 37 | 68 | 37 | |
3-5 | 214 | 13 | 22 | 12 | |
≥ 6 | 76 | 5 | 11 | 6 | |
Blind or disabled§ | .36 | ||||
Yes | 381 | 24 | 38 | 21 | |
No | 1,222 | 76 | 145 | 79 | |
Location of care | |||||
Assisted living care | .70 | ||||
Yes | 145 | 9 | 15 | 8 | |
No | 1,458 | 91 | 168 | 92 | |
Home health care | .02 | ||||
Yes | 846 | 53 | 80 | 44 | |
No | 757 | 47 | 103 | 56 | |
Procedures conducted between diagnosis and treatment | |||||
Additional biopsies | < .001 | ||||
Any | 154 | 10 | 36 | 20 | |
None | 1,449 | 90 | 147 | 80 | |
Medical imaging | .27 | ||||
Any | 83 | 5 | 13 | 7 | |
None | 1,520 | 95 | 170 | 93 | |
Hospitalization (not cancer related) | < .001 | ||||
Any | 39 | 2 | 15 | 8 | |
None | 1,564 | 98 | 168 | 92 | |
Emergency department visit (not cancer related) | < .001 | ||||
Any | 23 | 1 | 10 | 6 | |
None | 1,580 | 99 | 173 | 95 | |
Initial treatment information | |||||
Type of treatment first received | < .001 | ||||
Surgery | 1,334 | 83 | 117 | 64 | |
Radiation | 63 | 4 | 14 | 8 | |
Chemotherapy | 149 | 9 | 31 | 17 | |
Hormonal or biologic | 57 | 4 | 21 | 12 | |
Treatment types received | |||||
Surgery | .19‡ | ||||
Breast-conserving surgery | 579 | 36 | 77 | 42 | |
Mastectomy | 989 | 62 | 101 | 55 | |
None | 35 | 2 | 5 | 3 | |
Radiation therapy | .79 | ||||
Any | 824 | 51 | 96 | 53 | |
None | 779 | 49 | 87 | 48 | |
Chemotherapy | .05 | ||||
Any | 683 | 43 | 64 | 35 | |
None | 920 | 57 | 119 | 65 | |
Hormonal or targeted biologic therapy | .38 | ||||
Any | 458 | 29 | 58 | 32 | |
None | 1,145 | 71 | 125 | 68 |
NOTE. Percentages may not add to 100% because of rounding error.
Abbreviation: HPSA, health professional shortage area.
P value is from χ2 test.
Eight women did not have information about county of residence at diagnosis.
P value is from Fisher's exact test.
Only two women were blind.